PNV is another example. Check their chart.
As their strategy unfolds and FA strengthens, it positions the coy well for a future rerate IMO
Ann: Japanese Patent Office to grant key patent for Progenza, page-13
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
